Vitruvian Shield
Letter of interestNeurologyPT

Multiple sclerosis investigator-initiated study, ULS Coimbra

Coimbra investigators signed a non-binding letter of interest on 2 September 2026 for use of the platform in a future multiple sclerosis study.

Status
Letter of interest
Clinical site
ULS Coimbra

Principal investigator names and participant numbers are published on authorisation.

More on Neurology on Vitruvian Shield

See how Vitruvian Shield supports studies in this therapeutic area, from protocol preparation through remote monitoring.